Back to Search Start Over

A comparative study on antianginal effects of single topical application of 5mg NT-1 and 10mg NT-1 in patients with stable effort angina pectoris. A randomised double-blind cross-over study using multistage treadmill exercise testing

Authors :
Kazushige Kato
Haruo Inagaki
Kazuhito Shiki
Teruo Kondo
Yoshifumi Tanahashi
Haruo Hirayama
Iwao Sotobata
Mitsuyoshi Nakashima
Jitsuki Tsuzuki
Shoji Noda
Masato Tsuzuki
Source :
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 18:419-430
Publication Year :
1987
Publisher :
Japanese Society of Clinical Pharmacology and Therapeutics, 1987.

Abstract

NT-1 is a transdermal tape containing 5 mg nitroglycerin and is expected to havesustained efficacy of nitroglycerin.In order to compare the antianginal effects of 5mg NT-1 and 10 mg NT-1 on exercisetolerance, a ramdomised double-blind cross-over study was carried out in 19 patientswith stable effort angina pectoris. Multistage treadmill exercise testing was performedin all patients before and at 2 hours after a single topical application of 5 mg NT-1 or 10mg NT-1. It was also performed in 12 out of the 19 patients, as a open study, before andat 2 hours after a single topical application of a placebo tape. The exercise testing wasterminated at moderate anginal pain.Before topical application, there were no significant differences in treadmill exerciseduration, heart rate, systolic blood pressure, or ST deviation between 5 mg NT-1 or 10mg NT-1. At 2 hours after the application, systolic blood pressure at rest was morereduced with 10 mg NT-1 than with 5 mg NT-1. However, there were no significantdifferences in treadmill exercise duration, heart rate, systolic blood pressure at peakexercise, or ST deviation between 5 mg NT-1 and 10 mg NT-1. At 2 hours after a singletopical application of NT-1, the mean plasma level of nitroglycerin was twice as highwith 10 mg NT-1 as with 5 mg NT-1.In all 12 patients who were subjected to the placebo open study, treadmill exerciseduration was significantly longer with NT-1 than with placebo, irrespective of dosagestudied. However, there were no significant differences in systolic blood pressure, pressure-rate product, or ST deviation at peak exercise between NT-1 and placebo.These results indicate that the topical application of NT-1 significantly increasesexercise tolerance in patients with stable effort angina pectoris, and that the antianginaleffects of 5 mg NT-1 are approximately equal to those of 10 mg NT-1.

Details

ISSN :
18828272 and 03881601
Volume :
18
Database :
OpenAIRE
Journal :
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
Accession number :
edsair.doi...........f4ebf05a7242ea09d07fe8b6d7c41324